Pilot Grants Available – Apply by Sept 15, 2021
CDC, PerkinElmer Readying Molecular SMA Tests as Stakeholders Push for Nationwide Newborn Screening
Parents’ Experiences 12 Years after Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Their Attitudes to Whole-Genome Sequencing in Newborns
The FDA and 23andMe: Overreaching and overreacting?
Prenatal Identification of Increased Risk for Schizophrenia
Genetic Information Not Always Benign
Does Genetic Testing Pose Psychosocial Risks?
Columbia University to Explore Impact of Genetic Information about Autism on Families, Individuals
Examining the Impact of Genetic Data: A Thirteen-Year Retrospective of the Work of Columbia’s CEER
Exploring Origins and Impacts of Beliefs about Genetic Causation
Newborn Sequencing (NBSeq) – The Future of Newborn Screening
Expanding Newborn Screening through Genome Sequencing: An ELSI Perspective